Switch to
More onapp

How to use scorecard? Learn more

Alpa Laboratories Ltd

ALPA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹191 cr, stock is ranked 2,292
High RiskStock is 4.24x as volatile as Nifty
90.500.45 (-0.49%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

Avg

Can be considered moderately valued vs the market

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹191 cr, stock is ranked 2,292
High RiskStock is 4.24x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
10.65
PB RatioPB Ratio
1.42
Dividend YieldDiv. Yield
Sector PESector PE
42.84
Sector PBSector PB
6.03
Sector Div YldSctr Div Yld
0.63%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Alpa Laboratories Limited is a pharmaceutical company. The Company operates in the drugs and chemicals segment.

Financial TrendFinancial statements 

202020212022202388.88101.95123.05102.331.847.2414.1012.59
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Reply to Clarification- Financial results 
Announced OnMay 13, 2024

The Exchange had sought clarification from Alpa Laboratories Limited for the quarter ended 31-Dec-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is enclosed. | Download

The Exchange had sought clarification from Alpa Laboratories Limited for the quarter ended 31-Dec-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is enclosed. | Download

Trading Window-XBRL 
Announced OnApr 4, 2024

ALPA LABORATORIES LIMITED has informed the Exchange about Closure of Trading Window | Download

ALPA LABORATORIES LIMITED has informed the Exchange about Closure of Trading Window | Download

See all events